ONCOLOGY: Oblimersen Extends Survival in Chronic Lymphocytic Leukemia

Audio Journal of Oncology, December 10th, 2007 Reporting from: American Society of Hematology Annual Meeting, December 8-11 2007, Atlanta Oblimersen Extends Survival in Chronic Lymphocytic Leukemia SUSAN O'BRIEN, MD Anderson Cancer Center, Houston REFERENCE: ASH 2007 For patients with relapsed or refractory CLL, oblimersen extends survival when added to standard fludarabine/cyclophosphamide chemotherapy. Susan O’Brien presented data from this phase III trial to the American Society of Hematology meeting in Atlanta. Sarah Maxwell reports.

You can listen to ONCOLOGY: Oblimersen Extends Survival in Chronic Lymphocytic Leukemia online on Radio and Podcast. Open the player on this page to stream the available audio.

ONCOLOGY: Oblimersen Extends Survival in Chronic Lymphocytic Leukemia is an episode from Audio Medica News - Medical News Interviews by Audio Medica.

This episode is 00:04:56 long.

This episode was published on Dec 10, 2007.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Audio Medica News - Medical News Interviews when more episodes are available from the podcast feed.